Search results for " Control"

showing 10 items of 7691 documents

Lipid peroxidation and antioxidant enzyme activities in patients with type 1 diabetes mellitus

1999

To evaluate oxidative stress in type I diabetes mellitus, two antioxidant enzymes in erythrocytes, copper-zinc superoxide dismutase (SOD EC 1.15.1.1.) and seleno-dependent glutathione peroxidase (GSH-Px; EC 1.11.19), and two indexes of peroxidation in plasma, thiobarbituric acid reactive substances (TBARS) and organic hydroperoxides (OHP), were measured in 118 patients with insulin-dependent diabetes mellitus (IDDM), classified in accordance with the presence or absence of vascular complications and the degree of metabolic control established by the HbA1c level. Ninety healthy subjects made up the control group. According to our results, plasmatic TBARS and OHP concentrations are significan…

AdultMalemedicine.medical_specialtyErythrocytesAntioxidantThiobarbituric acidmedicine.medical_treatmentClinical BiochemistryThiobarbituric Acid Reactive SubstancesAntioxidantsLipid peroxidationchemistry.chemical_compoundInternal medicineDiabetes mellitusmedicineTBARSHumansTriglyceridesGlycated Hemoglobinchemistry.chemical_classificationGlutathione PeroxidaseSuperoxide DismutaseCholesterolGlutathione peroxidaseGeneral MedicineMiddle Agedmedicine.diseasePeroxidesOxidative StressCholesterolDiabetes Mellitus Type 1EndocrinologychemistryMetabolic control analysisRegression AnalysisFemaleLipid PeroxidationScandinavian Journal of Clinical and Laboratory Investigation
researchProduct

The effects of telmisartan alone or in combination with hydrochlorothiazide on morning home blood pressure control: The SURGE 2 practice-based study

2013

SURGE 2, a large-scale, practice-based study in 10 countries, evaluated the effects of telmisartan alone or with hydrochlorothiazide (HCTZ) on morning (06:00 – 11:59) home blood pressure (HBP) control. Hypertensive patients (clinic blood pressure [BP] 140/90 mmHg) received telmisartan 40 or 80 mg either alone or in combination with HCTZ 12.5 mg for 8 weeks. Treatment could be adjusted if clinic BP remained 140/90 mmHg. Clinic BP was measured in the morning prior to medication, and seated HBP monitoring was performed, three times per day, 2 days per week. A total of 25,882 patients were included (71% were previously using antihypertensives). There was a statistically signifi cant (all p 0.00…

AdultMalemedicine.medical_specialtyEveningAdolescentDiastoleBlood PressureBenzoatesYoung AdultHydrochlorothiazideInternal medicineInternal MedicinemedicineHumansProspective StudiesTelmisartanProspective cohort studyAdverse effectAntihypertensive AgentsMorningAgedAged 80 and overbusiness.industryHome blood pressure monitoring hydrochlorothiazide morning blood pressure control telmisartanGeneral MedicineMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREBlood Pressure Monitoring AmbulatoryMiddle AgedDrug CombinationsEndocrinologyBlood pressureHydrochlorothiazideAnesthesiaHypertensionBenzimidazolesFemaleTelmisartanCardiology and Cardiovascular MedicinebusinessAngiotensin II Type 1 Receptor Blockersmedicine.drug
researchProduct

Impact of the WHO depression guideline on patient care by psychiatrists: a randomized controlled trial.

2008

AbstractBackgroundScientific literature reviews aim to summarize the state of knowledge and published empirical evidence. In contrast, medical guidelines are intervention tools that aim to improve physician behaviour and patient outcome. They can have positive effects, but they can also have negative effects. Their effects must be tested by research.MethodsIn a randomized controlled trial, 103 psychiatrists in private practice were either provided with the WHO depression guideline only (information group), or provided with the WHO depression guideline and trained for one day in this guideline (intervention group), or left uninformed (control group). They then treated a total of 497 patients…

AdultMalemedicine.medical_specialtyEvidence-based practiceInservice TrainingMirtazapineMianserinAntidepressive Agents TricyclicWorld Health Organizationlaw.invention03 medical and health sciences0302 clinical medicineContinuing medical educationRandomized controlled triallawGermanymedicineHumans030212 general & internal medicinePsychiatryAgedPsychiatryDepressive Disorderbusiness.industryEvidence-based medicineGuidelineMiddle AgedMental health030227 psychiatryPsychiatry and Mental healthAffectPrivate practicePractice Guidelines as TopicPhysical therapyFemalebusinessPsychosocialEuropean psychiatry : the journal of the Association of European Psychiatrists
researchProduct

Comparison of Foot and Hand Reaction Times among Men: A Methodologic Study Using Simple and Multiple-Choice Repeated Measurements

1995

The primary study goal was to compare visual simple and choice reaction times of the hand and foot to assess validity of measurements for evaluating subjects' ability to perform rapid, controlled movements. First, we examined the repeatability ( N = 34) for four different data-sampling methods from a series of 12 trials within sessions and between two test sessions. Simple and choice reaction times with the preferred hand and both feet were then compared among 153 healthy male volunteers aged 35 to 67 years. Pearson correlations for hand and ipsilateral and contralateral foot reaction times on simple and choice tasks (.53 to .80, p<.001) showed that psychomotor foot reaction time is a v…

AdultMalemedicine.medical_specialtyExperimental and Cognitive PsychologyChoice BehaviorFunctional Laterality050105 experimental psychology03 medical and health sciences0302 clinical medicineReference ValuesReaction TimemedicineHumans0501 psychology and cognitive sciencesAgedMultiple choicePsychomotor learningFoot05 social sciences030229 sport sciencesRepeatabilityMiddle AgedHandSensory SystemsReference valuesPhysical therapyNeuromuscular controlPsychologyPsychomotor PerformanceFoot (unit)Perceptual and Motor Skills
researchProduct

Ciclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized and prospective study.

1986

Forty patients with Graves' ophthalmopathy stages III-V were divided into two groups in a random manner according to their year of birth. Group I received prednisone in decreasing dosage. Group II received prednisone at a comparable dosage and ciclosporin. Steroids were discontinued after 10 weeks in the two groups. In the patients of group II, ciclosporin was continued over 12 months. The therapeutic effect was assessed by an activity score based on subjective and objective symptoms (computerized tomography and sonography of the orbit, Hertel values, clinical findings). All signs of endocrine ophthalmopathy improved significantly in both groups (P less than 0.01 in group I; P less than 0.0…

AdultMalemedicine.medical_specialtyEye DiseasesClinical BiochemistryVisual AcuityCyclosporinsBiochemistryGastroenterologylaw.inventionGraves' ophthalmopathyPharmacotherapyRandomized controlled triallawPrednisoneInternal medicinemedicineHumansProspective StudiesProspective cohort studyClinical Trials as TopicDose-Response Relationship Drugbusiness.industryTherapeutic effectGeneral MedicineMiddle AgedCiclosporinmedicine.diseaseGraves DiseaseClinical trialEndocrinologyPrednisoneDrug Therapy CombinationFemalebusinessmedicine.drugFollow-Up StudiesEuropean journal of clinical investigation
researchProduct

Effect of manual therapy versus proprioceptive neuromuscular facilitation in dynamic balance, mobility and flexibility in field hockey players. A ran…

2018

To compare the effectiveness of a specific Manual Therapy (MT) protocol applied to field hockey players (FHP), versus a Proprioceptive Neuromuscular Facilitation (PNF) protocol, in the improvement of dynamic balance, active range of movement and lumbar flexibility one-week and four-weeks after the treatment.Randomized controlled trial. Participants were assigned to 2 groups: MT and PNF. 30 min' sessions were performed once a week for three weeks. Three evaluations were performed: basal, one-week and four-weeks post-treatment.University of Valencia (Spain).22 in MT group and 20 in PNF group.Dynamic Balance, measured with Star Excursion Balance Test; Active Range of Motion (ROM), using a manu…

AdultMalemedicine.medical_specialtyFlexibility (anatomy)Field hockeyAdolescentPhysical Therapy Sports Therapy and Rehabilitationlaw.invention03 medical and health sciencesYoung Adult0302 clinical medicinePhysical medicine and rehabilitationRandomized controlled triallawMuscle Stretching ExercisesmedicineHumansOrthopedics and Sports MedicineKneeRange of Motion ArticularDynamic balancePostural Balance030222 orthopedicsHipProprioceptionArthrometry Articularbusiness.industryLumbosacral Region030229 sport sciencesGeneral MedicineProprioceptionMusculoskeletal ManipulationsBiomechanical Phenomenamedicine.anatomical_structureHockeyAthletesAthletic InjuriesFemaleManual therapyAnkleAnklebusinessRange of motionPhysical therapy in sport : official journal of the Association of Chartered Physiotherapists in Sports Medicine
researchProduct

Are postural responses to backward and forward perturbations processed by different neural circuits?

2013

Item does not contain fulltext Startle pathways may contribute to rapid accomplishment of postural stability. Here we investigate the possible influence of a startling auditory stimulus (SAS) on postural responses. We formulated four specific questions: (1) can a concurrent SAS shorten the onset of automatic postural responses?; and if so (2) is this effect different for forward versus backward perturbations?; (3) does this effect depend on prior knowledge of the perturbation direction?; and (4) is this effect different for low- and high-magnitude perturbations? Balance was perturbed in 11 healthy participants by a movable platform that suddenly translated forward or backward. Each particip…

AdultMalemedicine.medical_specialtyFuture studiesDCN MP - Plasticity and memoryPerturbation (astronomy)Stimulus (physiology)Developmental psychologyPostural controlYoung AdultPhysical medicine and rehabilitationBiological neural networkmedicineReaction TimeHumansIn patientMuscle SkeletalPostural BalanceGeneral NeurosciencePosturographyHuman Movement & Fatigue DCN PAC - Perception action and control [NCEBP 10]Human Movement & Fatigue [DCN MP - Plasticity and memory NCEBP 10]Postural stabilityFemaleNerve NetPsychologyPsychomotor PerformanceNeuroscience
researchProduct

Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial

2004

We assessed the effectiveness and safety of an induction dose of peginterferon alfa-2b (PEG-IFN) plus ribavirin for initial treatment of patients with genotype 1 chronic HCV infection in a randomized, controlled, multicenter trial.Three hundred and eleven naïve patients infected with genotype 1 and chronic hepatitis were randomly assigned to 48-week treatment with PEG-IFN once weekly (80-100 micrograms depending on body weight for 8 weeks, followed by 50 micrograms for the next 40 weeks), or standard interferon alfa-2b (IFN) 6 million units on alternate days, both in combination with ribavirin (1000-1200 mg/day).PEG-IFN plus ribavirin significantly increased sustained virological response (…

AdultMalemedicine.medical_specialtyGenotypeCombination therapyFibrosiHepacivirusAlpha interferonHepacivirusInterferon alpha-2Antiviral AgentsGastroenterologyPolyethylene Glycolslaw.inventionchemistry.chemical_compoundRandomized controlled triallawMulticenter trialInternal medicineRibavirinmedicineHumansCombination therapyHepatologybiologybusiness.industryRibavirinfibrosisInterferon-alphavirus diseasesDrug ToleranceHepatitis CHepatitis C ChronicMiddle Agedbiology.organism_classificationmedicine.diseaseRecombinant Proteinsdigestive system diseasesMulticenter trial; Combination therapy; fibrosischemistryMulticenter trialImmunologyPeginterferon alfa-2bFemaleSafetybusinessmedicine.drugJournal of Hepatology
researchProduct

Combination therapy with amantadine and interferon in naı̈ve patients with chronic hepatitis C: meta-analysis of individual patient data from six cli…

2003

Abstract Background/Aims In chronic hepatitis C, clinical trials evaluating the efficacy of amantadine (AMA) and interferon (INF) compared to INF monotherapy, have produced conflicting results. We performed a meta-analysis of the individual patient's data from previous studies. Methods Nine hundred and seventy-two patients from six European centres were evaluated by means of individual patient meta-analysis, using mixed models with centres and the centre–treatment interaction fitted as random variables. Results At the end of therapy, virological responses were 38.5% (95% CI 34.1–42.8) after INF and AMA, and 29.5% (95% CI 25.5–33.6) after INF alone (P=0.003). Sustained response occurred in 1…

AdultMalemedicine.medical_specialtyGenotypeCombination therapyHepacivirusAntiviral AgentsGastroenterologymeta-analysilaw.inventionchemistry.chemical_compoundPharmacotherapyRandomized controlled triallawInternal medicineparasitic diseasesAmantadinemedicinechronic hepatitis CHumansAgedRandomized Controlled Trials as TopictherapyDose-Response Relationship DrugHepatologybusiness.industryRibavirinAmantadineAlanine TransaminaseinterferonHepatitis CHepatitis C ChronicMiddle AgedViral Loadrandomized clinical trialmedicine.diseaseClinical trialTreatment OutcomechemistryImmunologyDrug Therapy CombinationFemaleInterferonsbusinessViral loadmedicine.drugJournal of Hepatology
researchProduct

Individualized treatment duration for hepatitis C genotype 1 patients: a randomized controlled trial

2008

It was hypothesized that in hepatitis C virus (HCV) genotype 1 patients, variable treatment duration individualized by first undetectable HCV RNA is as effective as standard 48-week treatment. Patients (n_696) received peginterferon alfa-2a, 180 mg/week, or peginterferon alfa-2b, 1.5 mg/kg/week, plus ribavirin, 1000-1200 mg/day, for 48 weeks (standard, n _237) or for 24, 48, or 72 weeks if HCV-RNA–negative at weeks 4, 8, or 12, respectively (variable, n _ 459). Sustained virologic response (SVR) was achieved in 45.1% [95% confidence interval (CI) 38.8-51.4] of the patients in the standard group and in 48.8% (CI 44.2-53.3) of the patients in the variable group (P _ 0.37). The percentages of …

AdultMalemedicine.medical_specialtyGenotypeHepatitis C virusAlpha interferonHepacivirusInterferon alpha-2medicine.disease_causeAntiviral AgentsGastroenterologyDrug Administration SchedulePolyethylene Glycolslaw.inventionchemistry.chemical_compoundRandomized controlled triallawInternal medicineRibavirinmedicineHumansProspective StudiesRapid Virologic Responsegenotype 1Hepatologybusiness.industryRibavirinStandard treatmentInterferon-alphavirus diseasesHepatitis CMiddle Agedmedicine.diseaseRecombinant Proteinsdigestive system diseasesConfidence intervalSurgeryTreatment OutcomechemistryRNA ViralDrug Therapy CombinationFemalehepatitis Cbusiness
researchProduct